thoughts on fair market cap assuming trials replicate or improve on results already seen?
It’s obviously a bit of an art at this early stage, but since buying soon after IPO I’ve had $120m as a target that I think is not unreasonable considering peers and realistic chance of revenues flowing by 2026
keen to hear views of others
above not financial advice!
Ann: Trading Halt, page-14
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add LTP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
82.5¢ |
Change
0.045(5.77%) |
Mkt cap ! $58.08M | |||
| Open | High | Low | Value | Volume |
| 79.5¢ | 82.5¢ | 79.5¢ | $38.80K | 48.31K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2300 | 81.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 82.5¢ | 1500 | 1 |
View Market Depth
| Last trade - 10.24am 16/07/2024 (20 minute delay) ? |
| LTP (ASX) Chart |